Abstract
Sirolimus-eluting stents (SESs) are currently being used in patients undergoing percutaneous coronary intervention (PCI). SESs have not been evaluated in the treatment of acute myocardial infarction by primary angioplasty. We report our initial experience with SESs implanted during primary angioplasty. One hundred and three patients were treated within 12 hr after onset of acute myocardial infarction (AMI) with primary angioplasty and SES implantation. Those patients were compared to 504 patients treated with bare metal stents (BMSs). Angiographic success (TIMI flow grade 3 and residual stenosis < 50%) was completed in 98% of patients with SESs and no subacute stent thrombosis was reported. Inhospital outcomes were similar in the SES and BMS groups. At 6 months, major cardiac events were less frequent in the SES group than in the BMS group (9% vs. 24%, respectively; P < 0.001), driven by a lesser need for repeat revascularization with SESs (1% vs. 10.3% with BMSs; P = 0.014). Mortality at 6 months was 7% with SESs and 11% with BMSs (P = 0.14). SESs are safe and effective for the treatment of AMI by primary angioplasty. As compared to BMSs, SESs improve long-term outcome after AMI, mainly by reducing the need for repeat revascularization.
| Original language | English |
|---|---|
| Pages (from-to) | 469-472 |
| Number of pages | 4 |
| Journal | Catheterization and Cardiovascular Interventions |
| Volume | 65 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - 2005 Aug 1 |
| Externally published | Yes |
Fingerprint
Keywords
- Drug-eluting stent
- Myocardial infarction
- Percutaneous coronary intervention
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
- Radiology Nuclear Medicine and imaging
Cite this
Impact of sirolimus-eluting stents on outcomes of patients treated for acute myocardial infarction by primary angioplasty. / Cheneau, Edouard; Rha, Seung-Woon; Kuchulakanti, Pramod K.; Stabile, Eugenio; Kinnaird, Timothy; Torguson, Rebecca; Pichard, Augusto D.; Satler, Lowell F.; Kent, Kenneth M.; Waksman, Ron.
In: Catheterization and Cardiovascular Interventions, Vol. 65, No. 4, 01.08.2005, p. 469-472.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Impact of sirolimus-eluting stents on outcomes of patients treated for acute myocardial infarction by primary angioplasty
AU - Cheneau, Edouard
AU - Rha, Seung-Woon
AU - Kuchulakanti, Pramod K.
AU - Stabile, Eugenio
AU - Kinnaird, Timothy
AU - Torguson, Rebecca
AU - Pichard, Augusto D.
AU - Satler, Lowell F.
AU - Kent, Kenneth M.
AU - Waksman, Ron
PY - 2005/8/1
Y1 - 2005/8/1
N2 - Sirolimus-eluting stents (SESs) are currently being used in patients undergoing percutaneous coronary intervention (PCI). SESs have not been evaluated in the treatment of acute myocardial infarction by primary angioplasty. We report our initial experience with SESs implanted during primary angioplasty. One hundred and three patients were treated within 12 hr after onset of acute myocardial infarction (AMI) with primary angioplasty and SES implantation. Those patients were compared to 504 patients treated with bare metal stents (BMSs). Angiographic success (TIMI flow grade 3 and residual stenosis < 50%) was completed in 98% of patients with SESs and no subacute stent thrombosis was reported. Inhospital outcomes were similar in the SES and BMS groups. At 6 months, major cardiac events were less frequent in the SES group than in the BMS group (9% vs. 24%, respectively; P < 0.001), driven by a lesser need for repeat revascularization with SESs (1% vs. 10.3% with BMSs; P = 0.014). Mortality at 6 months was 7% with SESs and 11% with BMSs (P = 0.14). SESs are safe and effective for the treatment of AMI by primary angioplasty. As compared to BMSs, SESs improve long-term outcome after AMI, mainly by reducing the need for repeat revascularization.
AB - Sirolimus-eluting stents (SESs) are currently being used in patients undergoing percutaneous coronary intervention (PCI). SESs have not been evaluated in the treatment of acute myocardial infarction by primary angioplasty. We report our initial experience with SESs implanted during primary angioplasty. One hundred and three patients were treated within 12 hr after onset of acute myocardial infarction (AMI) with primary angioplasty and SES implantation. Those patients were compared to 504 patients treated with bare metal stents (BMSs). Angiographic success (TIMI flow grade 3 and residual stenosis < 50%) was completed in 98% of patients with SESs and no subacute stent thrombosis was reported. Inhospital outcomes were similar in the SES and BMS groups. At 6 months, major cardiac events were less frequent in the SES group than in the BMS group (9% vs. 24%, respectively; P < 0.001), driven by a lesser need for repeat revascularization with SESs (1% vs. 10.3% with BMSs; P = 0.014). Mortality at 6 months was 7% with SESs and 11% with BMSs (P = 0.14). SESs are safe and effective for the treatment of AMI by primary angioplasty. As compared to BMSs, SESs improve long-term outcome after AMI, mainly by reducing the need for repeat revascularization.
KW - Drug-eluting stent
KW - Myocardial infarction
KW - Percutaneous coronary intervention
UR - http://www.scopus.com/inward/record.url?scp=23044471223&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=23044471223&partnerID=8YFLogxK
U2 - 10.1002/ccd.20395
DO - 10.1002/ccd.20395
M3 - Article
VL - 65
SP - 469
EP - 472
JO - Catheterization and Cardiovascular Interventions
JF - Catheterization and Cardiovascular Interventions
SN - 1522-1946
IS - 4
ER -